Gold Nanoparticles in Nanomedicine: Unlocking Therapeutic Potential for Precision Diagnosis and Treatment

Abstract

Nanomedicine is a relatively new interdisciplinary field that combines medicine and nanotechnology. It offers remarkable opportunities for precise diagnosis and treatment. Because of the unique physicochemical properties that they possess, Gold Nanoparticles (GNPs) are used extensively in the field of nanomedicine. This study aims to introduce a novel approach known as Gold Nanoparticles in Nanomedicine (GNP-NM), which uses GNPs to enhance the precision of diagnosis and treatment for patients. Several noteworthy qualities are associated with GNP-NM, including therapeutic efficacy, considerable nanoparticle aggregation, controlled drug discharge, and remarkable biocompatibility. According to the data, the drug is delivered at an average rate of 9.99 µg/h, there is a high concentration of nanoparticles at 1.66E+11 particles/mL, the therapy is highly successful with therapeutic effectiveness of 92.1%, and the cells continue to be highly viable at 92.1% throughout the process. These findings demonstrate the robustness and dependability of the technique, suggesting that it can revolutionize nanomedical treatments significantly. Due to the many benefits that GNP-NM offers, it has the potential to become a platform for the expansion of precision medicine. This highlights the relevance of GNP-NM in defining the future outcomes of nanomedicine applications.